Literature DB >> 18669646

Bcl2L12-mediated inhibition of effector caspase-3 and caspase-7 via distinct mechanisms in glioblastoma.

Alexander H Stegh1, Santosh Kesari, John E Mahoney, Harry T Jenq, Kristin L Forloney, Alexei Protopopov, David N Louis, Lynda Chin, Ronald A DePinho.   

Abstract

Glioblastoma multiforme (GBM) is a highly aggressive brain cancer that is characterized by the paradoxical features of intense apoptosis resistance yet a marked propensity to undergo necrosis. Bcl2L12 (for Bcl2-Like12) is a nuclear and cytoplasmic oncoprotein that is universally overexpressed in primary GBM and functions to block postmitochondrial apoptosis signaling by neutralizing effector caspase-3 and caspase-7 maturation. This postmitochondrial block in apoptosis engenders the alternate cell fate of cellular necrosis, thus providing a molecular explanation for GBM's classical features. Whereas Bcl2L12-mediated neutralization of caspase-7 maturation involves physical interaction, the mechanism governing Bcl2L12-mediated inhibition of caspase-3 activity is not known. The nuclear localization of Bcl2L12 prompted expression profile studies of primary astrocytes engineered to overexpress Bcl2L12. The Bcl2L12 transcriptome revealed a striking induction of the small heat shock protein alpha-basic-crystallin (alphaB-crystallin/HspB5), a link reinforced by robust alphaB-crystallin expression in Bcl2L12-expressing orthotopic glioma and strong coexpression of alphaB-crystallin and Bcl2L12 proteins in human primary GBMs. On the functional level, enforced alphaB-crystallin or Bcl2L12 expression enhances orthotopic tumor growth. Conversely, RNAi-mediated knockdown of alphaB-crystallin in Bcl2L12-expressing astrocytes and glioma cell lines with high endogenous alphaB-crystallin showed enhanced apoptosis, yet decreased necrotic cell death with associated increased caspase-3 but not caspase-7 activation. Mirroring this specific effect on effector caspase-3 activation, alphaB-crystallin selectively binds pro-caspase-3 and its cleavage intermediates in vitro and in vivo. Thus, alphaB-crystallin is a Bcl2L12-induced oncoprotein that enables Bcl2L12 to block the activation of both effector caspases via distinct mechanisms, thereby contributing to GBM pathogenesis and its hallmark biological properties.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18669646      PMCID: PMC2504776          DOI: 10.1073/pnas.0712034105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  The small heat shock protein alpha B-crystallin negatively regulates cytochrome c- and caspase-8-dependent activation of caspase-3 by inhibiting its autoproteolytic maturation.

Authors:  M C Kamradt; F Chen; V L Cryns
Journal:  J Biol Chem       Date:  2001-03-23       Impact factor: 5.157

2.  The small heat shock protein alpha B-crystallin negatively regulates apoptosis during myogenic differentiation by inhibiting caspase-3 activation.

Authors:  Merideth C Kamradt; Feng Chen; Susan Sam; Vincent L Cryns
Journal:  J Biol Chem       Date:  2002-07-24       Impact factor: 5.157

3.  Antisense-mediated inhibition of the bcl-2 gene induces apoptosis in human malignant glioma.

Authors:  T Julien; B Frankel; S Longo; M Kyle; S Gibson; E Shillitoe; T Ryken
Journal:  Surg Neurol       Date:  2000-04

4.  APRIL, a new member of the tumor necrosis factor family, modulates death ligand-induced apoptosis.

Authors:  W Roth; B Wagenknecht; A Klumpp; U Naumann; M Hahne; J Tschopp; M Weller
Journal:  Cell Death Differ       Date:  2001-04       Impact factor: 15.828

5.  BCL-2 family protein expression in initial and recurrent glioblastomas: modulation by radiochemotherapy.

Authors:  H Strik; M Deininger; J Streffer; E Grote; J Wickboldt; J Dichgans; M Weller; R Meyermann
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-12       Impact factor: 10.154

6.  Soluble decoy receptor 3 is expressed by malignant gliomas and suppresses CD95 ligand-induced apoptosis and chemotaxis.

Authors:  W Roth; S Isenmann; M Nakamura; M Platten; W Wick; P Kleihues; M Bähr; H Ohgaki; A Ashkenazi; M Weller
Journal:  Cancer Res       Date:  2001-03-15       Impact factor: 12.701

7.  Down-regulation of Bcl-2 and Bcl-xL expression with bispecific antisense treatment in glioblastoma cell lines induce cell death.

Authors:  Zhihong Jiang; Xiao Zheng; Keith M Rich
Journal:  J Neurochem       Date:  2003-01       Impact factor: 5.372

8.  The PEA-15/PED protein protects glioblastoma cells from glucose deprivation-induced apoptosis via the ERK/MAP kinase pathway.

Authors:  A Eckert; B C Böck; K E Tagscherer; T L Haas; K Grund; J Sykora; C Herold-Mende; V Ehemann; M Hollstein; H Chneiweiss; O D Wiestler; H Walczak; W Roth
Journal:  Oncogene       Date:  2007-08-13       Impact factor: 9.867

9.  Oxygen and glucose deprivation induces mitochondrial dysfunction and oxidative stress in neurones but not in astrocytes in primary culture.

Authors:  Angeles Almeida; María Delgado-Esteban; Juan P Bolaños; José M Medina
Journal:  J Neurochem       Date:  2002-04       Impact factor: 5.372

10.  Model-based analysis of oligonucleotide arrays: model validation, design issues and standard error application.

Authors:  C Li; W Hung Wong
Journal:  Genome Biol       Date:  2001-08-03       Impact factor: 13.583

View more
  63 in total

1.  Glioblastoma-derived epidermal growth factor receptor carboxyl-terminal deletion mutants are transforming and are sensitive to EGFR-directed therapies.

Authors:  Jeonghee Cho; Sandra Pastorino; Qing Zeng; Xiaoyin Xu; William Johnson; Scott Vandenberg; Roel Verhaak; Andrew D Cherniack; Hideo Watanabe; Amit Dutt; Jihyun Kwon; Ying S Chao; Robert C Onofrio; Derek Chiang; Yuki Yuza; Santosh Kesari; Matthew Meyerson
Journal:  Cancer Res       Date:  2011-10-14       Impact factor: 12.701

2.  Spherical nucleic acid nanoparticle conjugates as an RNAi-based therapy for glioblastoma.

Authors:  Samuel A Jensen; Emily S Day; Caroline H Ko; Lisa A Hurley; Janina P Luciano; Fotini M Kouri; Timothy J Merkel; Andrea J Luthi; Pinal C Patel; Joshua I Cutler; Weston L Daniel; Alexander W Scott; Matthew W Rotz; Thomas J Meade; David A Giljohann; Chad A Mirkin; Alexander H Stegh
Journal:  Sci Transl Med       Date:  2013-10-30       Impact factor: 17.956

3.  BCL2L12A localizes to the cell nucleus and induces growth inhibition through G2/M arrest in CHO cells.

Authors:  Yi Hong; Junwu Yang; Yayun Chi; Wenzong Wang; Weibing Wu; Xiaojing Yun; Xiangfei Kong; Jianxin Gu
Journal:  Mol Cell Biochem       Date:  2010-01       Impact factor: 3.396

4.  The novel member of the BCL2 gene family, BCL2L12, is substantially elevated in chronic lymphocytic leukemia patients, supporting its value as a significant biomarker.

Authors:  Sotirios G Papageorgiou; Christos K Kontos; Vassiliki Pappa; Hellinida Thomadaki; Frida Kontsioti; John Dervenoulas; Efstathios Papageorgiou; Theofanis Economopoulos; Andreas Scorilas
Journal:  Oncologist       Date:  2011-07-07

5.  Wild-type and mutant p53 mediate cisplatin resistance through interaction and inhibition of active caspase-9.

Authors:  Jacqueline L Y Chee; Suzan Saidin; David P Lane; Sai Mun Leong; Jacqueline E Noll; Paul M Neilsen; Yi Ting Phua; Hani Gabra; Tit Meng Lim
Journal:  Cell Cycle       Date:  2012-01-15       Impact factor: 4.534

6.  Induction of the small heat shock protein alphaB-crystallin by genotoxic stress is mediated by p53 and p73.

Authors:  Joseph R Evans; Joshua D Bosman; Lauren Brown-Endres; Fruma Yehiely; Vincent L Cryns
Journal:  Breast Cancer Res Treat       Date:  2009-09-24       Impact factor: 4.872

7.  The small heat shock protein HspB2 is a novel anti-apoptotic protein that inhibits apical caspase activation in the extrinsic apoptotic pathway.

Authors:  Shayna E Oshita; Feng Chen; Toni Kwan; Fruma Yehiely; Vincent L Cryns
Journal:  Breast Cancer Res Treat       Date:  2010-01-20       Impact factor: 4.872

Review 8.  Survival signalling and apoptosis resistance in glioblastomas: opportunities for targeted therapeutics.

Authors:  Camilla Krakstad; Martha Chekenya
Journal:  Mol Cancer       Date:  2010-06-01       Impact factor: 27.401

9.  Lens fiber cell differentiation and denucleation are disrupted through expression of the N-terminal nuclear receptor box of NCOA6 and result in p53-dependent and p53-independent apoptosis.

Authors:  Wei-Lin Wang; Qingtian Li; Jianming Xu; Ales Cvekl
Journal:  Mol Biol Cell       Date:  2010-05-19       Impact factor: 4.138

Review 10.  Protein tyrosine phosphatases in glioma biology.

Authors:  Anna C Navis; Monique van den Eijnden; Jan T G Schepens; Rob Hooft van Huijsduijnen; Pieter Wesseling; Wiljan J A J Hendriks
Journal:  Acta Neuropathol       Date:  2009-11-21       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.